Zhangzhe K. Peng
87 Xiangya Road
Changsha, China
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 89 publications
Retraction notice to "Pyroptosis-related signatures predict immune characteristics and prognosis in IPF" [Heliyon 10 (2024) e23683].
Journal: Heliyon
Published: August 12, 2026
Caveolin-1 Stabilizes SERCA2 to Counteract Acute Kidney Injury via Suppression of Ca2+-Dependent Endoplasmic Reticulum Stress in Distal Tubules.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 01, 2025
Discovery of XRF-1021, a 2,4-disubstituted-5-fluoropyrimidine derivative as a homeodomain-interacting protein kinase 2 inhibitor for the treatment of chronic kidney disease.
Journal: European journal of medicinal chemistry
Published: September 01, 2025
SERCA2 deficiency in tubular epithelial cells drives ferroptosis in acute kidney injury regulating endoplasmic reticulum mitochondrial calcium homeostasis via voltage dependent anion channel 1 oligomerization.
Journal: Kidney international
Published: July 29, 2025
Age at disease onset and risk of chronic kidney disease in patients with heterozygous disease-causing variants in COL4A3 and COL4A4.
Journal: Clinical kidney journal
Published: May 21, 2025
Association of TyG-BMI and genetic risk with incident adult-onset asthma: Insights from the UK biobank.
Journal: Chinese medical journal
Published: May 09, 2025
Novel inflammation biomarkers in adult minimal change disease: predicting steroid-resistance and relapse.
Journal: European journal of medical research
Published: February 20, 2025
Peroxiredoxin-1 aggravates hypoxia-induced renal injury by promoting inflammation through the TLR4/MAPK/NF-κB signaling pathway.
Journal: Free radical biology & medicine
Published: February 05, 2025
Accuracy, satisfaction, and impact of custom GPT in acquiring clinical knowledge: Potential for AI-assisted medical education.
Journal: Medical teacher
Published: February 02, 2025
Research progress in anti-renal fibrosis drugs.
Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
Published: January 09, 2025
Peroxiredoxin 1 promotes intestinal inflammation by activating the NLRP3 inflammasome in macrophages through lysosomal disruption in Crohn's disease.
Journal: Cell death & disease
Published: November 23, 2024
Last Updated: 09/26/2026